Description: Collplant Holdings Ltd is a biotechnology company focused on regenerative medicine. It focused on developing & commercializing tissue repair products. Its products are based on recombinant human collagen produced from genetically-modified tobacco plants.
Home Page: www.collplant.com
CLGN Technical Analysis
Weizmann Science Park
Rehovot,
7670104
Israel
Phone:
972 73 232 5600
Officers
| Name | Title |
|---|---|
| Mr. Yehiel Tal | CEO & Director |
| Mr. Eran Rotem CPA | Deputy CEO & CFO |
| Dr. Ilana Belzer | Chief Operations Officer |
| Prof. Oded Shoseyov | Founder & Chief Scientist |
| Ms. Michal Roytman | VP of Sales & Marketing |
| Ms. Hadas Dreiher Horowitz | VP of HR |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: |
| Forward PE: | 4.9237 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 2.7123 |
| Price-to-Sales TTM: | 162.9776 |
| IPO Date: | 2018-01-30 |
| Fiscal Year End: | December |
| Full Time Employees: | 66 |